Clinical trials
Phase 1 Glucose Intolerance trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 6 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Texas Health Science Center at San Antonio | 2 |
| Vanderbilt University Medical Center | 2 |
| Veterans Medical Research Foundation | 2 |
| Afexa Life Sciences Inc | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Corcept Therapeutics | 1 |
| Indiana University | 1 |
| José A. Luchsinger | 1 |
| Mayo Clinic | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Intolerance | 16 |
| Diabetes Mellitus, Type 2 | 3 |
| Insulin Resistance | 3 |
| Prediabetic State | 3 |
| Diabetes Mellitus | 2 |
| Hyperglycemia | 2 |
| ACTH Syndrome, Ectopic | 1 |
| Adrenal Cortex Neoplasms | 1 |
| Adrenal Gland Diseases | 1 |
| Adrenocortical Carcinoma | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.